Length increase of the side chain of idoxifene does not improve its antagonistic potency in breast-cancer cell lines

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 4, 1998, Pages 339-342

  Jin, Lu ^a   Legros, Nicole ^a   Leclercq, Guy ^a   Hardcastle, Ian R ^b   Jarman, Michael ^b  

^a JULES BORDET INSTITUTE   (Belgium)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Antiestrogen; Idoxifene analogue; Mammary tumor; MCF 7 cells; RTX6 cells

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; ANTIESTROGEN; CB 7675; ESTROGEN RECEPTOR; IDOXIFENE; IDOXURIDINE DERIVATIVE; PROGESTERONE RECEPTOR; TAMOXIFEN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CHEMICAL MODIFICATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STRUCTURE ACTIVITY RELATION; TUMOR GROWTH;

BREAST NEOPLASMS; CELL DIVISION; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; STRUCTURE-ACTIVITY RELATIONSHIP; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0031975216     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050748     Document Type: Article

References (22)

1. Borgna JL, Coezy E, Rochefort H (1982) Mode of action of LN 1643 (a triphenylbromoethylene antiestrogen): probable mediation by the estrogen receptor and high affinity metabolite. Biochem Pharmacol 31: 3187
2. Borras M, Laios I, EI Khissiin A, Seo H-S, Lempereur F, Legros N, Leclercq G (1996) Estrogenic and antiestrogenic regulation of half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 57: 203
3. Burton KA (1956) A study of the conditions and mechanism of the diphenylamine reaction for colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315
4. Claussner A, Nédélec L, Nique F, Philibert D, Teutsch G, Van de Velde P (1992) 11β-Aminoalkyl estradiols, a new series of pure antiestrogens. J Steroid Biochem Mol Biol 41: 609
5. Duax WL (1981) Molecular details of receptor binding and hormonal action of steroid derived from X-ray crystallographic investigations. J Steroid Biochem 15: 41
6. Eckert RL, Katzenellenbogen BS (1992) Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res 42: 139
7. EORTC Breast Cancer Cooperative Group (1980) Revision of the standard for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513
8. Faye JC, Jozan S, Redeuilh G, Baulieu EE, Bayard F (1983) Physicochemical and genetic evidence for specific antiestrogen binding sites. Proc Natl Acad Sci USA 80: 3158
9. Hardcastle IR, Rowlands MG, Jarman M (1996) Anti-oestrogens as calmodulin antagonists. Curr Med Chem 3: 211
10. Hardcastle IR, Rowlands MG, Martin G, Grimshaw RM, Houghton J, Jarman M, Sharff A, Neidle S (1996) Homologues of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length. J Med Chem 39: 999
11. Jin L, Borras M, Lacroix M, Legros N, Leclercq G (1995) Antiestrogenic activity of two 11β-estradiol derivatives on MCF-7 breast cancer cells. Steroids 60: 512
12. Jordan VC, Gosden B (1982) importance of the alkyl-aminoethoxy side chain for estrogenic and antiestrogenic actions of trioxifene in the mature rat uterus. Mol Cell Endocrinol 27: 291
13. Leclercq G, Devleeschouwer N, Heuson JC (1983) Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for treatment of breast cancer. J Steroid Biochem 19: 73
14. Leclercq G, Legros N, Piccart MJ (1992) Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment. J Steroid Biochem Mol Biol 41: 545
15. Legros N, Jin L, Leclercq G (1997) Tamoxifen-induced estrogen receptor up-regulation in mammary tumor cells is not related to growth inhibition. Cancer Chemother Pharmacol 39: 380
16. Murphy CS, Jordan VC (1989) Structural components necessary for the antiestrogenic activity of tamoxifen. J Steroid Biochem 34: 407
17. Nique F, Van De Velde P (1995) RU 58668. Drugs Fut 20: 362
18. Quian X, Adul-Haji YJ (1990) Synthesis and biological activities of 11β-substituted estradiol as potential antiestrogens. Steroids 55: 238
19. Robertson DW, Katzenellenbogen JA, Hayes JR, Katzenellenbogen BS (1982) Antiestrogen basicity-activity relationship: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (z)-1,2-diphenyl-1-{4-[2-(dimethyl-amino)ethoxy]phenyl}-1-butene (tamoxifen, Nolvadex) having altered basicity. J Med Chem 25: 167
20. Van De Velde P, Nique F, Bouchoux F, Brémaud J, Hameau MC, Lucas D, Moratille C, Viet S, Philibert D, Teusch C (1994) RU 58 668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice. J Steroid Biochem Mol Biol 48: 187
21. Wakeling AE, Bowler J (1988) Novel antiestrogens without partial agonist activity. J Steroid Biochem 31: 645
22. Wolf DM, Fuqua SAW (1995) Mechanisms of action of anti-estrogens. Cancer Treat Rev 21: 247